-
1دورية أكاديمية
المؤلفون: Coutré, Steven E, Barrientos, Jacqueline C, Brown, Jennifer R, de Vos, Sven, Furman, Richard R, Keating, Michael J, Li, Daniel, O’Brien, Susan M, Pagel, John M, Poleski, Martin H, Sharman, Jeff P, Yao, Nai-Shun, Zelenetz, Andrew D
المصدر: Leukemia & Lymphoma, vol 56, iss 10
مصطلحات موضوعية: Biomedical and Clinical Sciences, Clinical Sciences, Cancer, Patient Safety, Digestive Diseases, Development of treatments and therapeutic interventions, Evaluation of treatments and therapeutic interventions, 6.1 Pharmaceuticals, 5.1 Pharmaceuticals, Good Health and Well Being, Algorithms, Antineoplastic Agents, Class Ia Phosphatidylinositol 3-Kinase, Diet Therapy, Disease Management, Drug-Related Side Effects and Adverse Reactions, Enzyme Inhibitors, Expert Testimony, Hematologic Neoplasms, Humans, Phosphatidylinositol 3-Kinases, Phosphoinositide-3 Kinase Inhibitors, Proto-Oncogene Proteins c-akt, Purines, Quinazolinones, Signal Transduction, TOR Serine-Threonine Kinases, Treatment Outcome, Idelalisib, phosphatidylinositol 3-kinase delta (PI3K) inhibitor
الوقت: 2779 - 2786
وصف الملف: application/pdf
العلاقة: qt9fb5063q; https://escholarship.org/uc/item/9fb5063qTest
-
2دورية أكاديمية
المؤلفون: Coutré, Steven E, Barrientos, Jacqueline C, Brown, Jennifer R, de Vos, Sven, Furman, Richard R, Keating, Michael J, Li, Daniel, O'Brien, Susan M, Pagel, John M, Poleski, Martin H, Sharman, Jeff P, Yao, Nai-Shun, Zelenetz, Andrew D
المصدر: Leukemia & lymphoma, vol 56, iss 10
مصطلحات موضوعية: Humans, Hematologic Neoplasms, Purines, Antineoplastic Agents, Enzyme Inhibitors, Treatment Outcome, Diet Therapy, Signal Transduction, Algorithms, Expert Testimony, Disease Management, Proto-Oncogene Proteins c-akt, Quinazolinones, Phosphatidylinositol 3-Kinases, Class Ia Phosphatidylinositol 3-Kinase, TOR Serine-Threonine Kinases, Drug-Related Side Effects and Adverse Reactions, Phosphoinositide-3 Kinase Inhibitors, Idelalisib, colitis, diarrhea, phosphatidylinositol 3-kinase delta (PI3Kδ) inhibitor, pneumonitis, transaminitis, Patient Safety, Digestive Diseases, Cancer, 5.1 Pharmaceuticals, Development of treatments and therapeutic interventions, 6.1 Pharmaceuticals
الوقت: 2779 - 2786
وصف الملف: application/pdf
العلاقة: qt6bs3281n; https://escholarship.org/uc/item/6bs3281nTest; https://escholarship.org/content/qt6bs3281n/qt6bs3281n.pdfTest
الإتاحة: https://doi.org/10.3109/10428194.2015.1022770Test
https://escholarship.org/uc/item/6bs3281nTest
https://escholarship.org/content/qt6bs3281n/qt6bs3281n.pdfTest